Millennium Management’s Lucid Diagnostics LUCD Stock Holding History

Millennium Management’s Portfolio LUCD Stock Details LUCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13K	Sell	11,320 -142,598	-93%	-$181K	﹤0.01%	5524
2025 Q4	$168K	Buy	+153,918	New	+$172K	﹤0.01%	5518
2025 Q2	–	Sell	-204,047	Closed	-$304K	–	6142
2025 Q1	$304K	Buy	+204,047	New	+$245K	﹤0.01%	5096
2023 Q1	–	Sell	-17,814	Closed	-$24K	–	6643
2022 Q4	$24K	Sell	17,814 -6,602	-27%	-$11.9K	﹤0.01%	6002
2022 Q3	$37K	Buy	24,416 +151	+0.6%	+$376	﹤0.01%	6275
2022 Q2	$55K	Buy	+24,265	New	+$53.9K	﹤0.01%	6164
2022 Q1	–	Sell	-65,315	Closed	-$351K	–	7235
2021 Q4	$351K	Buy	+65,315	New	+$530K	﹤0.01%	5382

Other funds holding LUCD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Millennium Management's LUCD Position: Q1 2026 in Review

Millennium Management reduced its Lucid Diagnostics (LUCD) stake by 93% in Q1 2026, selling an estimated $181K and leaving 11,320 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #5524.

Millennium Management first reported a position in LUCD in Q4 2021 and has held it in 7 quarters since. The position peaked at $351K in Q4 2021. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

Millennium Management held 11,320 shares of Lucid Diagnostics worth $13K as of Q1 2026.
Millennium Management sold 142,598 Lucid Diagnostics shares in Q1 2026, an estimated $181K.
Lucid Diagnostics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5524 holding.
Millennium Management first reported a position in Lucid Diagnostics in Q4 2021 and has held it in 7 quarters since.
Millennium Management's Lucid Diagnostics position peaked at $351K in Q4 2021.
103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.